IntraSpin System

The IntraSpin® system is the FDA-cleared & CE-marked medical device for the safe and rapid preparation of autologous Leukocyte- and Platelet-Rich Fibrin (L-PRF) from a small sample of blood taken chairside.


IntraSpin Advantages

The IntraSpin Advantage

  • Offers high-quality German-engineering and manufacturing with a set of parameters for the proper consistencies of L-PRF
  • Has been reported as the most stable centrifuge and offers up to 80% reduction in undesirable vibrations1
  • Features an optimized protocol that was scientifically developed and clinically proven from over 200 studies over 10+ years which ensures predictable results
  • Utilizes components that are FDA-cleared and CE-marked and have been optimized to ensure proper material biocompatibility and clinical performance


IntraSpin Advantages

Blood Collection

The Blood Sample Collection Set and materials have been selected for proper biocompatibilty, collection and maintenance of the blood sample.


The IntraSpin Centrifuge has a specific configuration and set of dynamic parameters. It has been calibrated and tested to ensure separation of the blood into proper segments and consistencies for Platelet Rich Fibrin.

IntraSpin Advantages
IntraSpin Advantages

Fabrication & Instrumentation

The Tissue Regeneration Kit includes the Xpression Box which is engineered to optimize the final step in the fabrication of Platelet Rich Fibrin. The weighted press is designed to express serum from the fibrin clot in a controlled manner and to form thin compressed layer of Platelet Rich Fibrin of a consistent thickness. A piston and cylinder assembly is used for the creation of Platelet Rich Fibrin plugs. The kit and instrumentation is also designed to aid incorporating graft material within the Platelet Rich Fibrin matrix.


  • bone defects
  • extraction sockets
  • sinus & dental ridge augmentation
  • palatal defects
  • maxillary bone atrophy



  1. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane, Platelets
    Ehrenfest David M. Dohan , Pinto Nelson R., Pereda Andrea, Jiménez Paula, Del Corso Marco, Kang Byung-Soo, Nally Mauricio, Lanata Nicole, Wang Hom-Lay, Quirynen Marc. (2017), DOI: 10.1080/09537104.2017.1293812. R43017b
  2. Reference manufacturer's Instructions for Use (IFU) package insert.

Not available in all countries.